GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo et al. · Cardiovascular Diabetology · 2021 · Meta-analysis
Full textCC BY
9 papersQuestions on this topic
Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo et al. · Cardiovascular Diabetology · 2021 · Meta-analysis
Full textCC BY
Allison Grech, Clare E Collins, Andrew Holmes et al. · Gut Microbes · 2021 · Meta-analysis
Full textCC BY
Lei Chen, Xiao-Jie Shi, Hua Liu et al. · Translational Psychiatry · 2021 · Meta-analysis
Full textCC BY
Shuhei Murao, Hidekazu Nakata, Ian Roberts et al. · Critical Care · 2021 · Meta-analysis
Full textCC BY
Moeko Tsutsuura, Hiromu Moriyama, Nana Kojima et al. · BMC Infectious Diseases · 2021 · Meta-analysis
Full textCC BY
Lucy McDonnell, Alexander Gilkes, Mark Ashworth et al. · Gut Microbes · 2021 · Meta-analysis
Full textCC BY
Shijiao Yan, Yong Gan, Nan Jiang et al. · Critical Care · 2020 · Meta-analysis
Full textCC BY
Danielle Greaves, Peter J. Psaltis, Daniel H. J. Davis et al. · Journal of the American Heart Association · 2020 · Meta-analysis
Full textCC BY
Jingjing Chen, Sufei Tian, Xiaoxu Han et al. · BMC Infectious Diseases · 2020 · Meta-analysis
Full textCC BY